Drug Type Fc fusion protein |
Synonyms- |
Target |
Action antagonists |
Mechanism p75NTR antagonists(Low affinity neurotrophin receptor p75NTR antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | United States | 30 Jan 2022 | |
| Brain Injuries, Traumatic | Preclinical | United States | 30 Jan 2022 | |
| Inflammatory pain | Preclinical | United States | 30 Jan 2022 | |
| Ischemic stroke | Preclinical | United States | 30 Jan 2022 |






